Bright Minds Biosciences (DRUG) had the highest return last year by a US stock in the Biotechnology Industry, returning 2,317.4%.

ASSET	YEAR	% RETURN
Bright Minds Biosciences (DRUG)	2024	2,317.45%
LENZ Therapeutics (LENZ)	2024	1,548.49%
Monopar Therapeutics (MNPR)	2024	1,229.31%
Mesoblast (MESO)	2024	816.67%
Zivo Bioscience Inc Warrants (ZIVOW)	2024	773.56%
Summit Therapeutics (SMMT)	2024	591.67%
Biofrontera Inc Warrants (BFRIW)	2024	507%
NeuroSense Therapeutics Ltd Warrant (NRSNW)	2024	486.67%
Candel Therapeutics (CADL)	2024	482.55%
Rezolute (RZLT)	2024	405.15%
Janux Therapeutics (JANX)	2024	401.31%
NewAmsterdam Pharma Company NV Warrant (NAMSW)	2024	371.85%
Exicure (XCUR)	2024	365.44%
Arcutis Biotherapeutics (ARQT)	2024	339.43%
Pasithea Therapeutics Corp Warrant (KTTAW)	2024	327.16%
Quantum-Si (QSIAW)	2024	316.67%
Jasper Therapeutics (JSPRW)	2024	310.16%
Emergent Biosolutions (EBS)	2024	306.81%
Benitec Biopharma Ltd ADR (BNTC)	2024	293.46%
ADMA Biologics (ADMA)	2024	281.11%
Humacyte (HUMAW)	2024	279.4%
Chimerix (CMRX)	2024	270.06%
Chemomab Therapeutics Ltd DRC (CMMB)	2024	254.9%
Praxis Precision Medicines (PRAX)	2024	246.04%
Entera Bio (ENTX)	2024	236.45%